Co-Authors
This is a "connection" page, showing publications co-authored by Yaseen Arabi and Hajar Alqahtani.
Connection Strength
0.117
-
Favipiravir and Hydroxychloroquine Combination Therapy in Patients with Moderate to Severe COVID-19 (FACCT Trial): An Open-Label, Multicenter, Randomized, Controlled Trial. Infect Dis Ther. 2021 Dec; 10(4):2291-2307.
Score: 0.060
-
A Trial of Favipiravir and Hydroxychloroquine combination in Adults Hospitalized with moderate and severe Covid-19: A structured summary of a study protocol for a randomised controlled trial. Trials. 2020 Oct 31; 21(1):904.
Score: 0.057